Regulation of synaptic transmission by CRF receptors. 2006

Luis Orozco-Cabal, and Sebastian Pollandt, and Jie Liu, and Patricia Shinnick-Gallagher, and Joel P Gallagher
Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX 77555-1031, USA.

Corticotropin-releasing factor (CRF or CRH) and its family of related peptides have long been recognized as hypothalamic-pituitary-adrenal (HPA) axis peptides that function to regulate the release of other hormones, e.g., ACTH. In addition, CRF acts outside the HPA axis not as a hormone, but as a regulator of synaptic transmission, pre- and post-synaptically, within specific CNS neuronal circuits. Synaptic transmission within the nervous system is today understood to be a more complex process compared to the concepts associated with the term 'synapse' introduced by Sherrington in 1897. Based on more than a century of progress with modern cellular and molecular experimental techniques, prior definitions and functions of synaptic molecules and their receptors need to be reconsidered (see Glossary and Fig. 1), especially in light of the important roles for CRF, its family of peptides and other potential endogenous regulators of neurotransmission, e.g., vasopressin, NPY, etc. (see Glossary). In addition, the property of 'constitutive activity' which is associated with G-protein coupled receptors (GPCRs) provides a persistent tonic mechanism to fine-tune synaptic transmission during both acute and chronic information transfer. We have applied the term 'regulator', adapted from the hormone literature, to CRF, as an example of a specific endogenous substance that functions to facilitate or depress the actions of neuromodulators on fast and slow synaptic responses. As such, synaptic neuroregulators provide a basic substrate to prime or initiate silently plastic processes underlying neurotransmitter-mediated information transfer at CNS synapses. Here we review the role of CRF to regulate CNS synaptic transmission and also suggest how under a variety of allostatic changes, e.g., associated with normal plasticity, or adaptations resulting from mental disorders, the synaptic regulatory role for CRF may be 'switched' in its polarity and/or magnitude in order to provide a coping mechanism to deal with daily and life-long stressors. Thus, a prominent role we assign to non-HPA axis CRF, its family of peptides, and their receptors, is to maintain both acute and chronic synaptic stability.

UI MeSH Term Description Entries
D009435 Synaptic Transmission The communication from a NEURON to a target (neuron, muscle, or secretory cell) across a SYNAPSE. In chemical synaptic transmission, the presynaptic neuron releases a NEUROTRANSMITTER that diffuses across the synaptic cleft and binds to specific synaptic receptors, activating them. The activated receptors modulate specific ion channels and/or second-messenger systems in the postsynaptic cell. In electrical synaptic transmission, electrical signals are communicated as an ionic current flow across ELECTRICAL SYNAPSES. Neural Transmission,Neurotransmission,Transmission, Neural,Transmission, Synaptic
D002490 Central Nervous System The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges. Cerebrospinal Axis,Axi, Cerebrospinal,Axis, Cerebrospinal,Central Nervous Systems,Cerebrospinal Axi,Nervous System, Central,Nervous Systems, Central,Systems, Central Nervous
D003346 Corticotropin-Releasing Hormone A peptide of about 41 amino acids that stimulates the release of ADRENOCORTICOTROPIC HORMONE. CRH is synthesized by neurons in the PARAVENTRICULAR NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, CRH stimulates the release of ACTH from the PITUITARY GLAND. CRH can also be synthesized in other tissues, such as PLACENTA; ADRENAL MEDULLA; and TESTIS. ACTH-Releasing Hormone,CRF-41,Corticotropin-Releasing Factor,Corticotropin-Releasing Hormone-41,ACTH-Releasing Factor,CRF (ACTH),Corticoliberin,Corticotropin-Releasing Factor-41,ACTH Releasing Factor,ACTH Releasing Hormone,Corticotropin Releasing Factor,Corticotropin Releasing Factor 41,Corticotropin Releasing Hormone,Corticotropin Releasing Hormone 41
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013312 Stress, Physiological The unfavorable effect of environmental factors (stressors) on the physiological functions of an organism. Prolonged unresolved physiological stress can affect HOMEOSTASIS of the organism, and may lead to damaging or pathological conditions. Biotic Stress,Metabolic Stress,Physiological Stress,Abiotic Stress,Abiotic Stress Reaction,Abiotic Stress Response,Biological Stress,Metabolic Stress Response,Physiological Stress Reaction,Physiological Stress Reactivity,Physiological Stress Response,Abiotic Stress Reactions,Abiotic Stress Responses,Abiotic Stresses,Biological Stresses,Biotic Stresses,Metabolic Stress Responses,Metabolic Stresses,Physiological Stress Reactions,Physiological Stress Responses,Physiological Stresses,Reaction, Abiotic Stress,Reactions, Abiotic Stress,Response, Abiotic Stress,Response, Metabolic Stress,Stress Reaction, Physiological,Stress Response, Metabolic,Stress Response, Physiological,Stress, Abiotic,Stress, Biological,Stress, Biotic,Stress, Metabolic
D018019 Receptors, Corticotropin-Releasing Hormone Cell surface proteins that bind corticotropin-releasing hormone with high affinity and trigger intracellular changes which influence the behavior of cells. The corticotropin releasing-hormone receptors on anterior pituitary cells mediate the stimulation of corticotropin release by hypothalamic corticotropin releasing factor. The physiological consequence of activating corticotropin-releasing hormone receptors on central neurons is not well understood. CRH Receptors,Corticotropin Releasing-Factor Receptor,Corticotropin Releasing-Hormone Receptors,Receptors, CRH,CRF Receptor,CRF Receptors,CRH Receptor,Corticotropin Releasing-Factor Receptors,Corticotropin Releasing-Hormone Receptor,Receptors, CRF,Corticotropin Releasing Factor Receptor,Corticotropin Releasing Factor Receptors,Corticotropin Releasing Hormone Receptor,Corticotropin Releasing Hormone Receptors,Corticotropin-Releasing Hormone Receptors,Hormone Receptors, Corticotropin-Releasing,Receptor, CRF,Receptor, CRH,Receptor, Corticotropin Releasing-Factor,Receptor, Corticotropin Releasing-Hormone,Receptors, Corticotropin Releasing Hormone,Receptors, Corticotropin Releasing-Factor,Receptors, Corticotropin Releasing-Hormone,Releasing-Factor Receptor, Corticotropin,Releasing-Factor Receptors, Corticotropin,Releasing-Hormone Receptor, Corticotropin,Releasing-Hormone Receptors, Corticotropin
D019970 Cocaine-Related Disorders Disorders related or resulting from use of cocaine. Cocaine Abuse,Cocaine Addiction,Cocaine Dependence,Abuse, Cocaine,Addiction, Cocaine,Cocaine Related Disorders,Cocaine-Related Disorder,Dependence, Cocaine,Dependences, Cocaine,Disorder, Cocaine-Related,Disorders, Cocaine-Related

Related Publications

Luis Orozco-Cabal, and Sebastian Pollandt, and Jie Liu, and Patricia Shinnick-Gallagher, and Joel P Gallagher
October 2007, Biochemical pharmacology,
Luis Orozco-Cabal, and Sebastian Pollandt, and Jie Liu, and Patricia Shinnick-Gallagher, and Joel P Gallagher
October 2000, British journal of pharmacology,
Luis Orozco-Cabal, and Sebastian Pollandt, and Jie Liu, and Patricia Shinnick-Gallagher, and Joel P Gallagher
March 2024, Molecular psychiatry,
Luis Orozco-Cabal, and Sebastian Pollandt, and Jie Liu, and Patricia Shinnick-Gallagher, and Joel P Gallagher
August 2007, Psychoneuroendocrinology,
Luis Orozco-Cabal, and Sebastian Pollandt, and Jie Liu, and Patricia Shinnick-Gallagher, and Joel P Gallagher
February 1992, Arzneimittel-Forschung,
Luis Orozco-Cabal, and Sebastian Pollandt, and Jie Liu, and Patricia Shinnick-Gallagher, and Joel P Gallagher
June 2004, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
Luis Orozco-Cabal, and Sebastian Pollandt, and Jie Liu, and Patricia Shinnick-Gallagher, and Joel P Gallagher
May 2016, Neuroscience,
Luis Orozco-Cabal, and Sebastian Pollandt, and Jie Liu, and Patricia Shinnick-Gallagher, and Joel P Gallagher
February 2004, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
Luis Orozco-Cabal, and Sebastian Pollandt, and Jie Liu, and Patricia Shinnick-Gallagher, and Joel P Gallagher
April 2008, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry,
Luis Orozco-Cabal, and Sebastian Pollandt, and Jie Liu, and Patricia Shinnick-Gallagher, and Joel P Gallagher
August 2004, Journal of bioenergetics and biomembranes,
Copied contents to your clipboard!